1. Home
  2. Analysis
  3. Minocycline-hydrochloride
  4. Modafinil

Minocycline hydrochloride and Modafinil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 9 people who take Minocycline hydrochloride and Modafinil. Common interactions include blood pressure decreased among females, and cholelithiasis among males.

The phase IV clinical study analyzes what interactions people who take Minocycline hydrochloride and Modafinil have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 04, 2023

9 people who take Minocycline hydrochloride and Modafinil together, and have interactions are studied.

What is Minocycline hydrochloride?

Minocycline hydrochloride has active ingredients of minocycline hydrochloride. It is used in acne. Currently, eHealthMe is studying from 4,744 Minocycline hydrochloride users.

What is Modafinil?

Modafinil has active ingredients of modafinil. It is used in narcolepsy. Currently, eHealthMe is studying from 19,411 Modafinil users.

Number of Minocycline hydrochloride and Modafinil reports submitted per year:

Minocycline hydrochloride and Modafinil drug interactions.

Common Minocycline Hydrochloride and Modafinil drug interactions by gender *:

female:

  1. Blood pressure decreased
  2. Cyanosis
  3. Depression
  4. Drug abuse
  5. Dysmenorrhoea
  6. Dysuria
  7. Flank pain
  8. Haematuria
  9. Headache
  10. Hypotension

male:

  1. Cholelithiasis
  2. Gynaecomastia

Common Minocycline Hydrochloride and Modafinil drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Breast cancer metastatic
  2. Abdominal pain upper
  3. Arthralgia
  4. Headache
  5. Influenza like illness
  6. Injection related reaction

40-49:

n/a

50-59:

n/a

60+:

  1. Accident
  2. Drug ineffective
  3. Hip fracture
  4. Nervousness

* Approximation only. Some reports may have incomplete information.

Do you take Minocycline hydrochloride and Modafinil?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Drug side effects by duration, gender and age:

Common Minocycline hydrochloride drug interactions:

Browse interactions between Minocycline hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Modafinil drug interactions:

Browse interactions between Modafinil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on minocycline hydrochloride and modafinil (the active ingredients of Minocycline hydrochloride and Modafinil, respectively), and Minocycline hydrochloride and Modafinil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Minocycline hydrochloride and Modafinil.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.